Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean A Gray

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Vaccines|August 28, 2025
Adjuvanted Protein Vaccines Boost RNA-Based Vaccines for Broader and More Potent Immune ResponsesJiho Kim, Jenn Davis, Bryan Berube, et al.
Protein Expression and Purification|June 11, 2005
Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coliKeith D Miller, Jane Weaver-Feldhaus, Sean A Gray, et al.
Expert Review of Vaccines|December 15, 2015
Development of a schistosomiasis vaccineAdebayo J Molehin, Juan U Rojo, Sabrina Z Siddiqui, et al.
Expert Review of Vaccines|September 7, 2021
Development of a recombinant vaccine against human onchocerciasisDavid Abraham, John Graham-Brown, Darrick Carter, et al.
Chemical Communications (Cambridge, England)|January 19, 2013
Label-free electrochemical detection of an Entamoeba histolytica antigen using cell-free yeast-scFv probesYadveer S Grewal, Muhammad J A Shiddiky, Sean A Gray, et al.
Biotechnology and Bioengineering|December 3, 2009
Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solutionSean A Gray, Kris M Weigel, Keith D Miller, et al.
Plos One|February 25, 2012
Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigensSean A Gray, Kris M Weigel, Ibne K M Ali, et al.
NPJ Vaccines|July 7, 2026
A next-generation human lymphatic filariasis vaccine candidate, rBmHAXT, for clinical developmentNithila Saravanan, Sean A Gray, Jennifer Davis, et al.
Plos Neglected Tropical Diseases|May 17, 2012
Proteomic analysis of the cyst stage of Entamoeba histolyticaIbne Karim M Ali, Rashidul Haque, Abdullah Siddique, et al.
Antiviral Research|April 26, 2016
Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in miceSean A Gray, Margaret Moore, Emily J VandenEkart, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Vaccines|August 28, 2025
Adjuvanted Protein Vaccines Boost RNA-Based Vaccines for Broader and More Potent Immune ResponsesJiho Kim, Jenn Davis, Bryan Berube, et al.
Protein Expression and Purification|June 11, 2005
Production, purification, and characterization of human scFv antibodies expressed in Saccharomyces cerevisiae, Pichia pastoris, and Escherichia coliKeith D Miller, Jane Weaver-Feldhaus, Sean A Gray, et al.
Expert Review of Vaccines|December 15, 2015
Development of a schistosomiasis vaccineAdebayo J Molehin, Juan U Rojo, Sabrina Z Siddiqui, et al.
Expert Review of Vaccines|September 7, 2021
Development of a recombinant vaccine against human onchocerciasisDavid Abraham, John Graham-Brown, Darrick Carter, et al.
Chemical Communications (Cambridge, England)|January 19, 2013
Label-free electrochemical detection of an Entamoeba histolytica antigen using cell-free yeast-scFv probesYadveer S Grewal, Muhammad J A Shiddiky, Sean A Gray, et al.
Biotechnology and Bioengineering|December 3, 2009
Flow cytometry-based methods for assessing soluble scFv activities and detecting antigens in solutionSean A Gray, Kris M Weigel, Keith D Miller, et al.
Plos One|February 25, 2012
Toward low-cost affinity reagents: lyophilized yeast-scFv probes specific for pathogen antigensSean A Gray, Kris M Weigel, Ibne K M Ali, et al.
NPJ Vaccines|July 7, 2026
A next-generation human lymphatic filariasis vaccine candidate, rBmHAXT, for clinical developmentNithila Saravanan, Sean A Gray, Jennifer Davis, et al.
Plos Neglected Tropical Diseases|May 17, 2012
Proteomic analysis of the cyst stage of Entamoeba histolyticaIbne Karim M Ali, Rashidul Haque, Abdullah Siddique, et al.
Antiviral Research|April 26, 2016
Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in miceSean A Gray, Margaret Moore, Emily J VandenEkart, et al.
Pageof 3